A Phase 3, Randomized, Double Blind, Saline Placebo and Active Controlled, Multicenter Study of HTX 011 Via Local Administration for Postoperative Analgesia and Decreased Opioid Use Following Unilateral Open Inguinal Herniorrhaphy
Phase of Trial: Phase III
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Acronyms EPOCH 2
- Sponsors Heron Therapeutics
- 09 Aug 2017 The results of this trial will support an NDA that Heron expects to file in 2018, according to a company media release.
- 01 Aug 2017 Status changed from planning to recruiting.
- 05 Jan 2017 New trial record